Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With BRCA Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen ...

The ERBB receptors are a group of receptor tyrosine kinases (RTKs ... and all except ERBB3 have relatively active kinase domains. Although ERBB2 is minimally active in ligand binding, it is ...